India’s Chemical Ambition: A Blueprint for Global Leadership
Key points from Chemical industry report published by the NITI Aayog
India’s chemical industry is set to be a cornerstone of the $5T economy vision. It already contributes 7% to India’s GDP, fuels sectors like pharma, textiles & agriculture and is the 6th largest globally.
By 2030, the industry is poised to reach $400–450B and $1 trillion by 2040.
This is India’s leap into global value chains. But there’s a gap. Despite growth, India’s share in global chemical consumption is just 3–3.5%.
In 2023, we ran a $31B trade deficit in chemicals.
Why?
95% of India’s propylene is converted to lower-value polypropylene (vs. 70% global)
75% of ethylene is converted to lower-value polyethylene (vs. 63% global)
This restricts diversification into high-value segments like MDI, fluorochemicals and battery chemicals.
Global supply chains are realigning post-COVID and amid US-China tensions. This is a once-in-a-generation opportunity. With China holding ~39% of global chemical capacity, even a 5–7% shift creates a $50–70B opportunity for India.
India has latent strengths in:
Agrochemicals
Pharma intermediates
Textile dyes
Now is the moment to scale up.
NITI Aayog outlines 4 Strategic Pillars to drive India’s chemical transformation:
Tap Export Markets: Focus on paints, dyes, agrochemicals
Grow Sunrise Sectors: EV battery, electronic chemicals
Solve Production Bottlenecks: Fix feedstock access for key inputs like styrene & phenol
Unlock Tech Access: Acquire IP/tech for MDI, acetic acid, etc.
A roadmap for global competitiveness.
To enable this, infrastructure is key. NITI proposes two critical interventions:
Develop World-Class Chemical Hubs inspired by Singapore’s Jurong Island ($40B investment, 4 MMTPA ethylene)
Upgrade PCPIRs in Gujarat, Odisha and Andhra with large-scale crackers, common utilities by fixing Port Infrastructure and improving storage, handling & last-mile linkages
A new inter-ministerial body will modernize 8 key chemical clusters.
Boosting production & innovation will need fiscal and R&D support:
Opex Subsidy Scheme for high-value products (e.g., pharma, agro intermediates)
Goal: INR 3L Cr turnover in 5 years
R&D Fund: $150–200M annually
India invests ~0.7% of chemical revenues in R&D vs 2.3% global avg. We require tech partnerships for advanced molecules (MDI, acetic acid, sustainable chemistries).
The regulatory & talent ecosystem also needs urgent fixes:
Fast-track EC Approvals
Current avg: 196 days (often 2 years total)
Goal: 6-month EC by 2026, with parallel clearances, “construct-at-risk” provisions
Rebalance FTAs
Protect sensitive sectors
Ensure duty-free access to critical raw materials
Fix Talent Gaps:
Expand ITIs, update curricula and build industry–academia bridges in chemical disciplines.
Vision 2030 — A globally competitive, self-reliant Indian chemical industry:
$220–280B in chemical output
5–6% global market share (from 3–3.5%)
"Net Zero" trade deficit
$35–40B in incremental exports
7–10 lakh new skilled jobs
Anchored in sustainability, technology, and infrastructure.
This transformation calls for joint action from the Govt (policy, infra, R&D), Industry (investment & tech), Academia (skilling & innovation) and Investors (long-term capital).
India has the blueprint. The world is watching. Let’s lead the next global chemical wave.
DISCLAIMER
Research Report prepared by Prateek Dugar.
SEBI Registered Corporate Research Analyst. Registration: Cupressus Enterprises Pvt Ltd (owner of Intelsense.in) - INH000013828.
Compliance Officer: Soumyadip Roy. Email: equity@intelsense.in
Registration granted by SEBI, membership of BASL (in case of IAs) and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.
This report is issued by Intelsense.in, which is regulated by the SEBI.
References to "Cupressus Enterprises Pvt Ltd" or “Intelsense.in” in this report shall mean Cupressus Enterprises Pvt Ltd unless otherwise stated. This report is prepared and distributed for information purposes only, and neither the information contained herein, nor any opinion expressed should be construed or deemed to be construed as solicitation or as offering advice for the purposes of the purchase or sale of any security, investment, or derivatives. The information and opinions contained in the report were considered by Intelsense.in to be valid when published. The report also contains information provided by third parties. The source of such information will usually be disclosed in the report. Whilst Intelsense.in has taken all reasonable steps to ensure that this information is correct, it does not offer any warranty as to the accuracy or completeness of such information. Any person placing reliance on the report to undertake trading does so entirely at his or her own risk and Intelsense.in does not accept any liability as a result. Securities and Derivatives markets may be subject to rapid and unexpected price movements and past performance is not necessarily an indication of future performance.
This report does not regard the specific investment objectives, financial situation, and the particular needs of any specific person who may receive this report. Investors must undertake independent analysis with their own legal, tax, and financial advisors and reach their own conclusions regarding the appropriateness of investing in any securities or investment strategies discussed or recommended in this report and should understand that statements regarding future prospects may not be realised. Under no circumstances can it be used or considered as an offer to sell or as a solicitation of any offer to buy or sell the securities mentioned within it. The information contained in the research reports may have been taken from trade and statistical services and other sources, which Intelsense.in believe is reliable. Intelsense.in, Cupressus Enterprises Pvt Ltd or any of its group/associate/affiliate companies do not guarantee that such information is accurate or complete and it should not be relied upon as such. Any opinions expressed reflect judgments at this date and are subject to change without notice.
 |
|